TIG Advisors LLC’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

TIG Advisors LLC’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-504,284	Closed	-$37.9M	–	220
2022 Q2	$37.9M	Buy	+504,284	New	+$22.4M	1.57%	19

TIG Advisors LLC's TPTX Position: Q3 2022 in Review

TIG Advisors LLC sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 504,284 shares — an estimated $37.9M sold.

TIG Advisors LLC first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $37.9M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

TIG Advisors LLC reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
TIG Advisors LLC sold 504,284 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $37.9M.
TIG Advisors LLC first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
TIG Advisors LLC's Turning Point Therapeutics, Inc. Common Stock position peaked at $37.9M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on TIG Advisors LLC's 13F filing for Q3 2022, filed 14 Nov 2022.